3 results
Approved WMOCompleted
The study aims to limit the use of anthracyclines and to reduce the dose of ATRA. Another aim is to stratify treatment by risk group: standard risk - WBC <10 x 109/l : high risk - WBC >=10 x 109/l. Furthermore this study aims to…
Approved WMORecruiting
The main objective is to study the efficacy of treatment with RTX in patients with relapsing PMR compared to placebo.
Approved WMORecruiting
The main objective is to study the efficacy of treatment with RTX in patients with newly diagnosed PMR compared to placebo.